Article
Molecular profiling in CLL.
Hematology. American Society of Hematology. Education Program - 1 Jan 2008
Gribben John G
Abstract excerpt
Chronic lymphocytic leukemia (CLL) has an extremely heterogeneous clinical course, with some patients requiring immediate therapy and others living without need for treatment for decades. There has been considerable interest in the underlying molecular mechanisms of this heterogeneity to understand not only the expected clinical course for individual patients but also the underlying pathogenesis of this disease....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
